Navigation Links
New Queen's spin-in company to revolutionize cancer detection
Date:7/23/2012

The development of novel medical imaging techniques to revolutionise cancer detection and treatment will be the result of a new partnership announced today between Queen's University Belfast and Cirdan Imaging Ltd.

The research will focus on developing new imaging equipment using X-rays and near Infrared (NIR) Fluorescence to assist clinicians in the detection, diagnosis and treatment of cancer.

Complete surgical removal of a tumour is vital for the patient, and one of the most important prognostic factors for survival. The new devices will be used in diagnostic procedures, as well as cancer surgery, to better discriminate between healthy and malignant tissue.

Cirdan Imaging's first new device will be an imaging tool developed to assist Radiologists to take a biopsy from a suspect lesion to help diagnose breast cancer. This product is planned to be launched within the next 12 months.

Queen's University have taken an equity shareholding in Cirdan Imaging Ltd through its venture spin-out company QUBIS Ltd, representing their first ever company spin-in.

Dr. Hugh Cormican is CEO of Cirdan Imaging. His previous collaboration with QUBIS led to the creation of Andor Technology, the fastest growing company manufacturing high performance digital cameras in the world today, employing some 260 people in 16 offices worldwide.

Speaking about the new partnership, Dr Cormican said: "I am delighted to be working with QUBIS and Queen's University again, and I look forward to the collaborative efforts in developing new cancer imaging techniques. We know that speed of detection and treatment of cancer is critical to patient outcomes and we hope that through this new faster, more efficient technology, patient outcomes and survival will be improved.

"Queen's University is one of the world's leading research centres for cancer research, and with our collaboration we can help bring the benefits of that research to impact on patient's lives in considerably shorter timescales than occur elsewhere in the world. In business terms we anticipate that there is also the potential to be the next IPO (AIM stock exchange listing) for Northern Ireland in five years time."

QUBIS CEO, Frank Bryan, said: "QUBIS is delighted to be involved in supporting this research initiative which will help develop safer, more cost effective, user friendly and compact diagnostic tools for early, more accurate diagnosis of cancer globally. Research into cancer has predominately been on getting an improved understanding of the disease, or on new therapeutics. Cirdan Imaging is focused on developing more accurate detection tools for the clinicians to better diagnose and treat the cancer, an area which has lagged behind. The team in Cirdan have an impressive track record in imaging technology and we are excited to be involved in this project."
'/>"/>

Contact: Claire O'Callaghan
c.ocallaghan@qub.ac.uk
Queen's University Belfast
Source:Eurekalert

Related medicine news :

1. Feelings of immaturity accompany alcohol misuse into adulthood; discovery could improve treatments
2. San Francisco Bath Salt Company Clears Air About Bath Salt Confusion – Zombies Beware!
3. Article Marketing Company Content Writing King Announces Training Of New Graphic Design Artist
4. Through The Use Of Twitter, EverSmoke, A Popular Electronic Cigarettes Company, Is Encouraging Fans to Finish the Hashtag #iPlanToBe With What They Plan to Be
5. SingleSource Background Screening Company Calls On Adults To Take Proactive Approach To Stop Child Sexual Abuse
6. Polar RCX5 Tour de France Available At The Heart Rate Watch Company
7. The Biochar Company Partners with Hawaii Biochar Products
8. Coral Calcium Company Announces New Offer Amidst Supreme Court Healthcare Decisions
9. Study Suggests Vaccine May Help Kids With Brain Cancer
10. New Stool Test Might Aid in Early Detection of Colon Cancer
11. Study reveals how cancer drug causes diabetic-like state
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... Raton, FL (PRWEB) , ... January 20, 2017 , ... ... development, announced it attended the January ECRM trade show to continue the marketing and ... advanced vitamin C supplement, known for providing 400 percent better absorption than traditional vitamin ...
(Date:1/20/2017)... ... January 20, 2017 , ... Lice Troopers, the lice ... in families with school-aged children since the holiday season. , “It happens every ... their families, sharing hugs and taking photos, which is the head-to-head gateway that lice ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... highest level of nutritional and bodybuilding supplements, announced it attended the January ECRM trade ... a respected bodybuilder and nutritional scientist who was determined to create a line of ...
(Date:1/20/2017)... ... January 20, 2017 , ... "TransFlare 4K Mystique comes with 44 ... Cut Pro X," said Christina Austin - CEO of Pixel Film Studios. , ... Dragon Sensor,TransFlare 4K Mystique lens flare and light leak transitions have a very high-dynamic ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is ... life of the woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater ... spent her career as an educator interacting with countless women who had little knowledge ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase Inhibitors, Serotonin Receptor Agonists, ... anti-obesity drugs market is expected to grow at a CAGR ... CAGR of 38.7% in the second half of the forecast period. ... from 2016 to 2027. The market is estimated at $1,058 million ... ...
(Date:1/19/2017)... , January 19, 2017 ... European Oncology & Haematology, 2016;12(Suppl 2):3-8; http://www.touchoncology.com/articles/optimising-clinical-outcomes-gastrointestinal-cancers-through-inhibiting-angiogenesis-and ... ... Published recently in a supplement ... journal from touchONCOLOGY, an article by James ...
(Date:1/19/2017)...   Science Exchange , the leading marketplace ... the first five replication studies from the ... in eLife today. Despite intense scrutiny around reproducibility ... evaluation of reproducibility rates that may identify specific ... assessments of reproducibility, the results of this project ...
Breaking Medicine Technology: